Table 3: Variables with significant variation by sex, age, and diagnosis delay.

Number (%) OR [CI 95%] p-value (X2)
Significant variations by gender
Oculomotor palsy Women 12 (28.9) 10.16 [1.2-82.9] 0.008 (6.52)
Men 1 (3.8)
Pathological brain imaging Women 28 (62.2) 3.11 [1.13-8.52] 0.01 (5.03)
Men 9 (34.6)
Tuberculomas Women 18 (40.0) 5.11 [1.3-19.6] 0.009 (6.40)
Men 3 (11.5)
Significant variations by age
Glasgow score < 10 Age < 65 years 3 (5.0) 10.7 [1.9-57.8] 0.009 (10.1)
Age ≥ 65 years 5 (45.5)
Mortality Age < 65 years 1 (1.7) 0.03 [0.003-0.3] 0.001 (15.2)
Age ≥ 65 years 4 (33.3)
Pathological brain imaging Age < 65 years 34 (57.6) 4.08 [1.001-16.62] 0.04 (4.2)
Age ≥ 65 years 3 (25)
Significant variations by delay diagnosis
Tuberculomas ≤ 30 days 11 (23.9) 0.3 [0.1-0.9] 0.03 (4.4)
> 30 days 10 (50.0)
Hydrocéphalus ≤ 30 days 3 (6.5) 0.13 [0.03-0.57] 0.006 (8.8)
> 30 days 7 (35.0)
Low glucose levels in CSF ≤ 30 days 26 (61.5) 0.2 [0.04-0.99] 0.03 (4.4)
> 30 days 18 (88.9)